The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Late-life rapamycin treatment reverses age-related heart dysfunction
Open accessAbstract
Rapamycin has been shown to extend lifespan in numerous model organisms including mice, with the most dramatic longevity effects reported in females. However, little is known about the functional ramifications of this longevity-enhancing paradigm in mammalian tissues. We treated 24-month-old female C57BL/6J mice with rapamycin for 3 months and determined health outcomes via a variety of noninvasive measures of cardiovascular, skeletal, and metabolic health for individual mice. We determined that while rapamycin has mild transient metabolic effects, there are significant benefits to late-life cardiovascular function with a reversal or attenuation of age-related changes in the heart. RNA-seq analysis of cardiac tissue after treatment indicated inflammatory, metabolic, and antihypertrophic expression changes in cardiac tissue as potential mechanisms mediating the functional improvement. Rapamycin treatment also resulted in beneficial behavioral, skeletal, and motor changes in these mice compared with those fed a control diet. From these findings, we propose that late-life rapamycin therapy not only extends the lifespan of mammals, but also confers functional benefits to a number of tissues and mechanistically implicates an improvement in contractile function and antihypertrophic signaling in the aged heart with a reduction in age-related inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Self-citationInflammatory networks during cellular senescence: causes and consequences.
Freund, A., Orjalo, A. V., Desprez, P.-Y., & Campisi, J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.003 · Cited by 1,354
Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., & Benzer, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.059 · Cited by 1,293
Self-citationRapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Lamming, D. W., Ye, L., Katajisto, P., Goncalves, M. D., Saitoh, M., Stevens, D. M., Davis, J. G., Salmon, A. B., Richardson, A., Ahima, R. S., et al. (2012) · Science · doi:10.1126/science.1215135 · Cited by 1,199
Influence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de Cabo, R., Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., et al. (2011) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq178 · Cited by 896
Self-citationA guide to analysis of mouse energy metabolism
Tschöp, M. H., Speakman, J. R., Arch, J. R. S., Auwerx, J., Brüning, J. C., Chan, L., Eckel, R. H., Farese, R. V., Galgani, J. E., Hambly, C., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1806 · Cited by 813
Tei, C., Nishimura, R. A., Seward, J. B., & Tajik, A. J. (1997) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(97)70090-7 · Cited by 784
Schieke, S. M., Phillips, D., McCoy, J. P., Aponte, A. M., Shen, R.-F., Balaban, R. S., & Finkel, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603536200 · Cited by 623
Wilkinson, J. E., Burmeister, L., Brooks, S. V., Chan, C., Friedline, S., Harrison, D. E., Hejtmancik, J. F., Nadon, N., Strong, R., Wood, L. K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00832.x · Cited by 619
Self-citationMcMullen, J. R., Sherwood, M. C., Tarnavski, O., Zhang, L., Dorfman, A. L., Shioi, T., & Izumo, S. (2004) · Circulation · doi:10.1161/01.cir.0000130641.08705.45 · Cited by 518
Overexpression of Catalase Targeted to Mitochondria Attenuates Murine Cardiac Aging
Dai, D.-F., Santana, L. F., Vermulst, M., Tomazela, D. M., Emond, M. J., MacCoss, M. J., Gollahon, K., Martin, G. M., Loeb, L. A., Ladiges, W. C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.822403 · Cited by 502
Fraenkel, M., Ketzinel-Gilad, M., Ariav, Y., Pappo, O., Karaca, M., Castel, J., Berthault, M.-F., Magnan, C., Cerasi, E., Kaiser, N., et al. (2008) · Diabetes · doi:10.2337/db07-0922 · Cited by 380
Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
Blagosklonny, M. V. (2006) · Cell Cycle · doi:10.4161/cc.5.18.3288 · Cited by 368
Direct control of mitochondrial function by mTOR
Ramanathan, A., & Schreiber, S. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912074106 · Cited by 365
Reduced Disability and Mortality Among Aging Runners: A 21-Year Longitudinal Study
Chakravarty, E. F. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1638 · Cited by 313
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
Witzig, T. E., Reeder, C. B., LaPlant, B. R., Gupta, M., Johnston, P. B., Micallef, I. N., Porrata, L. F., Ansell, S. M., Colgan, J. P., Jacobsen, E. D., et al. (2011) · Leukemia · doi:10.1038/leu.2010.226 · Cited by 297
Echocardiographic Speckle-Tracking Based Strain Imaging for Rapid Cardiovascular Phenotyping in Mice
Bauer, M., Cheng, S., Jain, M., Ngoy, S., Theodoropoulos, C., Trujillo, A., Lin, F.-C., & Liao, R. (2011) · Circulation Research · doi:10.1161/circresaha.110.239574 · Cited by 247
Shah, Y. M., Ma, X., Morimura, K., Kim, I., & Gonzalez, F. J. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00528.2006 · Cited by 231
Phosphoinositide-3 Kinase Signaling in Cardiac Hypertrophy and Heart Failure
Aoyagi, T., & Matsui, T. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796390976 · Cited by 213
Current biochemistry, molecular biology, and clinical relevance of natriuretic peptides
Nishikimi, T., Kuwahara, K., & Nakao, K. (2011) · Journal of Cardiology · doi:10.1016/j.jjcc.2011.01.002 · Cited by 198
Duration of Rapamycin Treatment Has Differential Effects on Metabolism in Mice
Fang, Y., Westbrook, R., Hill, C., Boparai, R. K., Arum, O., Spong, A., Wang, F., Javors, M. A., Chen, J., Sun, L. Y., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.008 · Cited by 195
de Groot, L. C. P. M. G., Verheijden, M. W., de Henauw, S., Schroll, M., & van Staveren, W. A. (2004) · The Journals of Gerontology: Series A · doi:10.1093/gerona/59.12.1277 · Cited by 189
Recent progress toward understanding the molecular mechanisms that regulate skeletal muscle mass
Goodman, C. A., Mayhew, D. L., & Hornberger, T. A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.07.013 · Cited by 180
Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis
Gao, X.-M., Wong, G., Wang, B., Kiriazis, H., Moore, X.-L., Su, Y.-D., Dart, A., & Du, X.-J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000239304.01496.83 · Cited by 160
Cardiac mTOR protects the heart against ischemia-reperfusion injury
Aoyagi, T., Kusakari, Y., Xiao, C.-Y., Inouye, B. T., Takahashi, M., Scherrer‐Crosbie, M., Rosenzweig, A., Hara, K., & Matsui, T. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00241.2012 · Cited by 152
Mizuguchi, Y., Oishi, Y., Miyoshi, H., Íuchi, A., Nagase, N., & Oki, T. (2009) · Journal of Cardiology · doi:10.1016/j.jjcc.2009.07.006 · Cited by 149
Song, X., Kusakari, Y., Xiao, C., Kinsella, S., Rosenberg, M. A., Scherrer‐Crosbie, M., Hara, K., Rosenzweig, A., & Matsui, T. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00338.2010 · Cited by 142
Design of aging intervention studies: the NIA interventions testing program
Nadon, N. L., Strong, R., Miller, R. A., Nelson, J., Javors, M., Sharp, Z. D., Peralba, J. M., & Harrison, D. E. (2008) · AGE · doi:10.1007/s11357-008-9048-1 · Cited by 142
Self-citationYang, S., Lee, H. Y., Young, D. M., Tien, A., Rowson-Baldwin, A., Shu, Y., Jan, Y. N., & Jan, L. Y. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0834-3 · Cited by 116
Buyse, G., der Mieren, G. V., Erb, M., D’hooge, J., Herijgers, P., Verbeken, E. K., Jara, A., den Bergh, A. V., Mertens, L., Courdier-Fruh, I., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn406 · Cited by 104
Yada, H., Murata, M., Shimoda, K., et al. (2007) · Circulation Research · doi:10.1161/circresaha.106.146399 · Cited by 77
Rad As a Novel Regulator of Excitation–Contraction Coupling and β-Adrenergic Signaling in Heart
Wang, G., Zhu, X., Xie, W., Han, P., Li, K., Sun, Z., Wang, Y., Chen, C., Song, R., Cao, C., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.208272 · Cited by 74
Downregulation of transcription factor, Sp1, during cellular senescence
Oh, J., Han, J.-A., & Hwang, E. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.118 · Cited by 72
Age-related loss of muscle fibres is highly variable amongst mouse skeletal muscles
Sheard, P. W., & Anderson, R. D. (2011) · Biogerontology · doi:10.1007/s10522-011-9365-0 · Cited by 61
A novel library screen identifies immunosuppressors that promote osteoblast differentiation
Darcy, A., Meltzer, M., Miller, J., Lee, S. S., Chappell, S., Donck, K. V., & Montano, M. A. (2012) · Bone · doi:10.1016/j.bone.2012.03.001 · Cited by 60
The evolving role of mTOR inhibition in transplantation tolerance.
McMahon, G., Weir, M., Li, X.-C., & Mandelbrot, D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040351 · Cited by 57
Püntmann, V. O., Taylor, P. C., & Mayr, M. (2010) · Gerontology · doi:10.1159/000316577 · Cited by 42
Miller, A. M., Brestoff, J. R., Phelps, C. B., Berk, E. Z., & Reynolds, T. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90428.2008 · Cited by 40
Smink, J. J., & Leutz, A. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0567-8 · Cited by 39
Astrinidis, A., Kim, J., Kelly, C. M., Olofsson, B. A., Torabi, B., Sorokina, E. M., & Azizkhan‐Clifford, J. (2009) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20739 · Cited by 32
Rodent Models of Aging Bone: An Update
Syed, F. A., & Melim, T. L. (2011) · Current Osteoporosis Reports · doi:10.1007/s11914-011-0074-z · Cited by 28
Chew, C.-H., Ng, D.-L., Tie, S.-W., Ong, P.-C., Lim, W.-S., Muhammad, T. S. T., & Choo, Q.-C. (2011) · Electronic Journal of Biotechnology · doi:10.2225/vol14-issue3-fulltext-9 · Cited by 3
Cited by
From discoveries in ageing research to therapeutics for healthy ageing
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019) · Nature · doi:10.1038/s41586-019-1365-2 · Cited by 1,389
Self-citationCellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338
Self-citationmTOR inhibition improves immune function in the elderly
Mannick, J. B., Del Giudice, G., Lattanzi, M., Valiante, N. M., Praestgaard, J., Huang, B., Lonetto, M. A., Maecker, H. T., Kovarik, J., Carson, S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009892 · Cited by 786
Miller, R. A., Harrison, D. E., Astle, C. M., Fernandez, E., Flurkey, K., Han, M., Javors, M. A., Li, X., Nadon, N. L., Nelson, J. F., et al. (2014) · Aging Cell · doi:10.1111/acel.12194 · Cited by 621
Self-citationThe mechanistic target of rapamycin: the grand conducTOR of metabolism and aging
Kennedy, B. K., & Lamming, D. W. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.009 · Cited by 544
Self-citation
Metadata
- Authors
- Flynn, J. M., O'Leary, M. N., Zambataro, C. A., Academia, E. C., Presley, M. P., Garrett, B. J., Zykovich, A., Mooney, S. D., Strong, R., Rosen, C. J., Kapahi, P., Nelson, M. D., Kennedy, B. K., & Melov, S.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2013-07-07
- Volume
- 12
- Issue
- 5
- Pages
- 851-862
- ISSN
- 1474-9718 (ISSN-L)
- OpenAlex
- W2019041167
- Cited by
- 311
- References
- 43
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.